Clinicopathological parameters | Endothelial area (mean ± SD/1 mm2) | P | Microvascular density (mean ± SD/1 mm2) | P |
---|---|---|---|---|
Histological type (n = 134) | ||||
Carcinoma simple (n = 24) | 2370.59 × 10–2 ± 546.39 µm | NS | 115.68 ± 51.74 | NS |
Carcinoma solid (n = 19) | 2632.44 × 10–2 ± 519.34 µm | 81.94 ± 32.23 | ||
Comedocarcinoma (n = 9) | 2787.11 × 10–2 ± 829.01 µm | 89.79 ± 37.99 | ||
Carcinoma arising in a complex/mixed tumour (n = 3) | 2549.33 × 10–2 ± 564.63 µm | 51.32 ± 3.51 | ||
Carcinoma complex (n = 30) | 2420.02 × 10–2 ± 569.64 µm | 77.05 ± 32.69 | ||
Carcinoma mixed (n = 32) | 2189.73 × 10–2 ± 438.96 µm | 82.11 ± 37.58 | ||
Intraductal papillary carcinoma (n = 13) | 2574.37 × 10–2 ± 492.51 µm | 73.04 ± 30.42 | ||
Adenosquamous carcinoma (n = 4) | 3100.95 × 10–2 ± 804.37 µm | 118.25 ± 111.5 | ||
Histological grade (n = 13) | ||||
Grade I (n = 73) | 2283.02 × 10–2 ± 516.64 µma | 0.001 | 90.4 ± 44.12 | NS |
Grade II (n = 34) | 2511.01 × 10–2 ± 526.49 µm | 87.72 ± 48.73 | ||
Grade III (n = 27) | 2820.39 × 10–2 ± 613.56 µma | 78.86 ± 32.3 | ||
Tumour necrosis (n = 134) | ||||
Absent (n = 73) | 2401.42 × 10–2 ± 581.02 µm | NS | 80.96 ± 39.28 | 0.047 |
Present (n = 61) | 2506.26 × 10–2 ± 567.85 µm | 94.22 ± 46.96 | ||
Tumour-infiltrating lymphocytes (n = 112) | ||||
Low (n = 55) | 2447.44 × 10–2 ± 630.6 µm | NS | 89.8 ± 46.99 | NS |
Moderate (n = 38) | 2441.75 × 10–2 ± 556.49 µm | 90.01 ± 39.22 | ||
High (n = 19) | 2321 × 10–2 ± 484.13 µm | 86.11 ± 50.37 | ||
Mitotic index (n = 134) | ||||
Low (n = 67) | 2278.36 × 10–2 ± 534.91 µma | 0.001 | 90.94 ± 49.05 | NS |
Moderate (n = 27) | 2532.93 × 10–2 ± 465.75 µm | 89.1 ± 41.01 | ||
High (n = 40) | 2678.64 × 10–2 ± 625.2 µma | 78.96 ± 33.21 | ||
Nuclear pleomorphism (n = 134) | ||||
Mild (n = 16) | 2318.88 × 10–2 ± 483.38 µm | NS | 85.34 ± 31.25 | NS |
Moderate (n = 82) | 2397.22 × 10–2 ± 577.76 µm | 57.74 ± 42.91 | ||
Marked (n = 36) | 2625.31 × 10–2 ± 582.27 µm | 86.02 ± 49.4 | ||
Tubular formation (n = 134) | ||||
Marked (n = 79) | 2302.75 × 10–2 ± 519.61 µma | 0.003 | 88.07 ± 44.42 | NS |
Moderate (n = 20) | 2507.79 × 10–2 ± 513.41 µm | 87.88 ± 32.17 | ||
Mild (n = 35) | 2746.06 × 10–2 ± 574.39 µma | 86.89 ± 43.28 | ||
Proliferation index (n = 134) | ||||
≤ 11% (n = 66) | 2342.96 × 10–2 ± 576.48 µm | 0.031 | 85.9 ± 48.4 | NS |
> 11% (n = 67) | 2557.68 × 10–2 ± 561.58 µm | 88.74 ± 37.88 | ||
Tumour size (n = 45) | ||||
T1 < 3 cm (n = 11) | 2129.6 × 10–2 ± 412.69 µm | NS | 85.53 ± 62.2 | NS |
T2 3–5 cm (n = 10) | 2611.14 × 10–2 ± 443.57 µm | 84.08 ± 32.58 | ||
T3 > 5 cm (n = 24) | 2472.56 × 10–2 ± 586.65 µm | 90.53 ± 54.98 | ||
Lymph node metastasis (n = 45) | ||||
Yes (n = 10) | 2440.42 × 10–2 ± 543.54 µm | NS | 89 ± 51.06 | NS |
No (n = 35) | 2374.24 × 10–2 ± 543.52 µm | 82.13 ± 55.35 |